Skip to content
drillr.ai
Sign up

002873.SZ

Guiyang Xintian Pharmaceutical Co., Ltd.

SZSE · Healthcare · C 制造业 · CN

CNY 7.54
+0.00%
Ask drillr

  • Oct 28, 2026, 11:02 UTC

    Xintian Pharmaceutical reported first-nine-month 2026 revenue of 503 million yuan, down 9.87% year over year, and attributable net profit of 16.7057 million yuan, up 3.24%.

    Source:

  • Oct 28, 2026, 11:02 UTC

    Xintian Pharmaceutical reported third-quarter 2026 revenue of 172 million yuan, down 14.32% year over year, and attributable net profit of 11.8443 million yuan, up 13.72%.

    Source:

  • Oct 13, 2026, 09:54 UTC

    New Tian Zhiyao extended the pledge on 20.6738 million shares of New Tian Pharmaceutical, representing 33.63% of its holdings and 8.47% of the company’s total shares, with Huachuang Securities as pledgee; the extension does not involve new financing.

    Source:

  • Jul 23, 2026, 09:45 UTC

    Xintian Pharmaceutical received one invention patent and two design patents from the China National Intellectual Property Administration.

    Source: